Eje microbiota-Intestino-Cerebro
Resumen
Las enfermedades neurodegenerativas y su relación con el sistema inmune y digestivo han despertado un interés importante en las ciencias de la salud por su impacto social y económico. El objetivo del presente estudio es contextualizar la evidencia emergente sobre el papel de la microbiota intestinal en las enfermedades neurodegenerativas y del neurodesarrollo, para lo cual se llevó a cabo una revisión documental de publicaciones científicas sobre el tema. Se encontró que la microbiota intestinal tiene un papel decisivo en las interacciones bidireccionales entre intestino y sistema nervioso y muchos de los efectos parecen estar asociados a ciertas cepas probióticas, lo que pudiese constituir una nueva estrategia adyuvante para el manejo de trastornos neurológicos.
Descargas
Citas
Appleton J. (2018). The gut-brain axis: Influence of microbiota on mood and mental health. Integrative Medicine: A Clinician's Journal, 17(4), 28.
Belkaid Y, Hand T. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121-141.
Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, et al. (2011). The intestinal microbiota affects central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology, 141(2), 599-609.
Berer K, Martínez I, Walker A, Kunkel B, Schmitt-Kopplin P, Walter J, Krishnamoorthy G. (2018). Dietary non-fermentable fiber prevents autoimmune neurological disease by changing gut metabolic and immune status. Scientific reports, 8(1), 10431.
Berger P, Plows J, Jones R, Alderete T, Yonemitsu C, Poulsen M, et al. (2020). Human milk oligosaccharide 2’-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers. PloS one, 15(2), e0228323.
Bhattacharjee S, Lukiw W. (2013). Alzheimer's disease and the microbiome. Frontiers in cellular neuroscience, 7, 153.
Blanco J, Oteo J. (2013). Gut microbiota: so much to explore! Expert Review of Anti-infective Therapy, 11(8), 759-761.
Boudry G, Charton E, Le Huerou I, Ferret S, Le Gall S, Even S, et al. (2021). The relationship between breast milk components and the infant gut microbiota. Frontiers in nutrition, 8, 629740.
Carabotti M, Scirocco A, Maselli M, Severi C. (2015). The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Annals of gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology, 28(2), 203.
Carr L, Virmani M, Rosa F, Munblit D, Matazel K, Elolimy A, et al. (2021). Role of human milk bioactives on infants' gut and immune health. Frontiers in immunology, 12, 604080.
Cenit M, Sanz Y, Codoñer P. (2017). Influence of gut microbiota on neuropsychiatric disorders. World journal of gastroenterology, 23(30), 5486.
Cerdó T, Ruíz A, Suárez A, Campoy C. (2017). Probiotic, prebiotic, and brain development. Nutrients, 9(11), 1247.
Cho Y. (2021). Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection. Gut and Liver, 15(1), 1.
Coelho G, Ayres L, Barreto D, Henriques B, Prado M, Passos C. (2021). Acquisition of microbiota according to the type of birth: an integrative review. Rev. Latino-Am. Enfermagem, 29, e3446.
Cohen L, Cho J, Gevers D, Chu H. (2019). Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology, 156(8), 2174-2189.
De Angelis M, Francavilla R, Piccolo M, De Giacomo A, Gobbetti M. (2015). Autism spectrum disorders and intestinal microbiota. Gut microbes, 6(3), 207-213.
DeGruttola A, Low D, Mizoguchi A, Mizoguchi E. (2016). Current understanding of dysbiosis in disease in human and animal models. Inflammatory bowel diseases, 22(5), 1137-1150.
Dinan T, Stanton C, Cryan J. (2013). Psychobiotics: a novel class of psychotropic. Biological psychiatry, 74(10), 720-726.
Dupont A, Heinbockel L, Brandenburg K, Hornef M. (2014). Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa. Gut microbes, 5(6), 761-765.
Duque M, Acero F. (2011). Composición y funciones de la flora bacteriana intestinal. Revista Repertorio de Medicina y Cirugía, 20(2), 74-82.
Felice V, Quigley E, Sullivan A, O'Keeffe G, O'Mahony S. (2016). Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism & related disorders, 27, 1-8.
Forte N, Fernández A, Palomba L, Di Marzo V, Cristino L. (2020). Obesity Affects the Microbiota–Gut–Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators. International Journal of Molecular Sciences, 21(5), 1554
Galley J, Nelson M, Yu Z, Dowd S, Walter J, Kumar P, et al. (2014). Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC microbiology, 14(1), 1-13.
Gérard P. (2016). Gut microbiota and obesity. Cellular and molecular life sciences, 73(1), 147-162.
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Disability Weights. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2020.
Gómez M, Ramón J, Pérez L, Blanco J. (2019). El eje microbiota-intestino-cerebro y sus grandes proyecciones. Rev Neurol, 68(3), 111-7.
Han Y, Wang B, Gao H, He C, Hua R, Liang C, et al. (2022). Vagus Nerve and Underlying Impact on the Gut Microbiota-Brain Axis in Behavior and Neurodegenerative Diseases. Journal of Inflammation Research, 6213-6230.
Hata T, Asano Y, Yoshihara K, Kimura T, Miyata N, Zhang X, et al. (2017). Regulation of gut luminal serotonin by commensal microbiota in mice. PloS one, 12(7), e0180745.
Hill D, Artis D. (2009). Intestinal bacteria and the regulation of immune cell homeostasis. Annual review of immunology, 28, 623-667.
Hill J, Bhattacharjee S, Pogue A, Lukiw W. (2014). The gastrointestinal tract microbiome and potential link to Alzheimer’s disease. Frontiers in neurology, 5, 43.
Hirano T, Nakase H. (2021). The Multifaceted Effects of Gut Microbiota on the Immune System of the Intestinal Mucosa. Immuno, 1(4), 583-594.
Icaza M. (2013). Microbiota intestinal en la salud y la enfermedad. Revista de gastroenterología de México, 78(4), 240-248.
Khan I, Bai Y, Zha L, Ullah N, Ullah H, Shah S. (2021). Mechanism of the gut microbiota colonization resistance and enteric pathogen infection. Frontiers in Cellular and Infection Microbiology, 1273.
Łubiech K, Twarużek M. (2020). Lactobacillus bacteria in breast milk. Nutrients, 12(12), 3783.
Marshall J, Warrington R, Watson W, Kim H. (2018). An introduction to immunology and immunopathology. Allergy, Asthma & Clinical Immunology, 14(2), 1-10.
Mart’yanov S, Botchkova E, Plakunov V, Gannesen A. (2021). The impact of norepinephrine on mono-species and dual-species staphylococcal biofilms. Microorganisms, 9(4), 820.
Mielcarz D, Kasper L. (2015). The gut microbiome in multiple sclerosis. Current treatment options in neurology, 17, 1-10.
Mittal R, Debs L, Patel A, Nguyen D, Patel K, O'Connor G, et al. (2017). Neurotransmitters: The critical modulators regulating gut–brain axis. Journal of cellular physiology, 232(9), 2359-2372.
Morris G, Berk M, Carvalho A, Caso J, Sanz, Y, Walder K, Maes, M. (2017). The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease. Molecular neurobiology, 54, 4432-4451.
Moser B, Milligan M, Dao M. (2022). The microbiota-Gut-Brain axis: Clinical applications in obesity and type 2 diabetes. Revista de investigación clínica, 74(6), 302-313.
Mueller N, Bakacs E, Combellick J, Grigoryan Z, Domínguez M. (2015). The infant microbiome development: mom matters. Trends in molecular medicine, 21(2), 109-117.
Musso G, Gambino R, Cassader M. (2010). Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes care, 33(10), 2277-2284.
Nagao H, Kitamoto S, Kuffa P, Kamada N. (2016). Pathogenic role of the gut microbiota in gastrointestinal diseases. Intestinal research, 14(2), 127.
Neuman H, Debelius J, Knight R, Koren O. (2015). Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS microbiology reviews, 39(4), 509-521.
Ornelas A, Dowdell A, Lee J, Colgan S. (2022). Microbial metabolite regulation of epithelial cell-cell interactions and barrier function. Cells, 11(6), 944.
Parker A, Fonseca S, Carding S. (2020). Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes, 11(2), 135-157.
Raoult D. (2008). Obesity pandemics and the modification of digestive bacterial flora. European Journal of Clinical Microbiology & Infectious Diseases, 27, 631-634.
Rogers G, Keating D, Young R, Wong M, Licinio J, Wesselingh S. (2016). From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Molecular psychiatry, 21(6), 738-748.
Rolfe R. (2000). The role of probiotic cultures in the control of gastrointestinal health. The Journal of nutrition, 130(2), 396S-402S.
Romano J, Weitkamp J. (2015). Maternal influences on fetal microbial colonization and immune development. Pediatric research, 77(1), 189-195.
Sharon G, Garg N, Debelius J, Knight R, Dorrestein P, et al. (2014). Specialized metabolites from the microbiome in health and disease. Cell metabolism, 20(5), 719-730.
Sherwin E, Sandhu K, Dinan T, Cryan J. (2016). May the force be with you: the light and dark sides of the microbiota–gut–brain axis in neuropsychiatry. CNS drugs, 30(11), 1019-1041.
Sian J. (2022). Wilful pathogens provoke a gut feeling in Parkinson’s disease. Journal of Neural Transmission, 129(5-6), 557-562.
Takanaga H, Ohtsuki S, Hosoya K, Terasaki T. (2001). GAT2/BGT-1 as a system responsible for the transport of γ-aminobutyric acid at the mouse blood–brain barrier. Journal of Cerebral Blood Flow & Metabolism, 21(10), 1232-1239.
Takiishi T, Fenero C, Câmara N. (2017). Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue barriers, 5(4), e1373208.
Thursby E, Juge N. (2017). Introduction to the human gut microbiota. Biochemical journal, 474(11), 1823-1836.
Tiffany C & Bäumler A. (2019). Dysbiosis: from fiction to function. American Journal of Physiology-Gastrointestinal and Liver Physiology, 317(5), G602-G608.
Van Bodegom M, Homberg J, Henckens M. (2017). Modulation of the hypothalamic-pituitary-adrenal axis by early life stress exposure. Frontiers in cellular neuroscience, 11, 87.
Wang Y & Kasper L. (2014). The role of microbiome in central nervous system disorders. Brain, behavior, and immunity, 38, 1-12.
Wei L, Singh R, Ro S, Ghoshal U. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976-987.
Weng M, Walker W. (2013). The role of gut microbiota in programming the immune phenotype. Journal of developmental origins of health and disease, 4(3), 203-214.
Williams B, Van Benschoten A, Cimermancic P, Donia M, Zimmermann M, Taketani M, et al. (2014). Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell host & microbe, 16(4), 495-503.
Wu H, Wu E. (2012). The role of gut microbiota in immune homeostasis and autoimmunity. Gut microbes, 3(1), 4-14.
Yan F, Polk D. (2020). Probiotics and probiotic-derived functional factors—mechanistic insights into applications for intestinal homeostasis. Frontiers in immunology, 11, 1428.
Yogeswara I, Maneerat S, Haltrich D. (2020). Glutamate decarboxylase from lactic acid bacteria—A key enzyme in GABA synthesis. Microorganisms, 8(12), 1923.
Yoo J, Groer M, Dutra S, Sarkar A, McSkimming D. (2020). Gut microbiota and immune system interactions. Microorganisms, 8(10), 1587.
Yoshikawa K, Kurihara C, Furuhashi H, Takajo T, Maruta K, Yasutake Y, et al. (2017). Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling. Journal of gastroenterology, 52, 61-71.
Young R, Huffman S. (2003). Probiotic use in children. Journal of Pediatric Health Care, 17(6), 277-283.
Zheng D, Liwinski T, Elinav E. (2020). Interaction between microbiota and immunity in health and disease. Cell research, 30(6), 492-506.
Zhu X, Li B, Lou P, Dai T, Chen Y, Zhuge A, et al. (2021). The relationship between the gut microbiome and neurodegenerative diseases. Neuroscience Bulletin, 37(10), 1510-1522.
Derechos de autor 2023 Adalberto Llinás Delgado;Rusvelt Vargas Moranth
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.jpg)
